Description
An inhibitor of plasma kallikrein (Ki = 0.81 μM); reduces bradykinin generation induced by kaolin and λ-carrageenan ex vivo in human plasma; prolongs partial thromboplastin and euglobulin clot lysis times; reduces hyperplasia, pannus formation, and infiltration of inflammatory cells in the tarsal joint of mice with collagen-induced arthritis
Formal name: 4-[[(2S)-2-[[[trans-4-(aminomethyl)cyclohexyl]carbonyl]amino]-1-oxo-3-phenylpropyl]amino]-benzeneacetic acid, monohydrochloride
Synonyms:
Molecular weight: 474
CAS: 128837-71-8
Purity: ≥95%
Formulation: A solid
Product Type|Biochemicals|Small Molecule Inhibitors|Blood Coagulation Factors||Product Type|Biochemicals|Small Molecule Inhibitors|Peptidases & Proteases||Research Area|Cardiovascular System|Blood|Thrombosis||Research Area|Immunology & Inflammation|Autoimmunity|Rheumatoid Arthritis